Actilyse Cathflo 2mg, Pulver zur Herstellung einer Injektionslösung

7680586650030 CH-58665 Pulver
Actilyse Cathflo 2mg, Pulver zur Herstellung einer Injektionslösung
Actilyse Cathflo 2mg, Pulver zur Herstellung einer Injektionslösung
Actilyse Cathflo 2mg, Pulver zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/10/2025
Summary of Product Characteristics
Français
16/10/2025
Summary of Product Characteristics
Italien
16/10/2025

Detailed composition

Substance Quantity Type Category
PRC
2.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
58665
Drug name
Actilyse Cathflo 2mg, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
B01AD02
Authorization status
Z
Dispensing category
B
First authorization
10/07/2009
Authorization expiration date
31/12/9999
IT Number
06.05.0.
Domain
Human medicine
Field of application
Rekanalisation thrombotisch verschlossener zentraler Venenzugänge

Package details

Description (FR)
ACTILYSE Cathflo subst sèche 2 mg flac 5 pce
Description (DE)
ACTILYSE Cathflo Trockensub 2 mg Durchstf 5 Stk
Market launch
10/07/2009
Narcotic (BTM)
No

Other package sizes (1)

ACTILYSE Cathflo 2 mg c solv flac 5 pce
None None
GTIN: 7680586650023
Not in V1